Improvement of individual quality of life in caregivers and patients under L-dopa/carbidopa duodenal infusion therapy

被引：0
|
作者：
Ehlers, C.
Honig, H.
Odin, P.
机构：
来源：
MOVEMENT DISORDERS | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1405
引用
收藏
页码：S541 / S542
页数：2
相关论文
共 50 条
  • [41] INTRAVENOUS L-DOPA PLUS CARBIDOPA IN DEPRESSED-PATIENTS - AVERAGE EVOKED-RESPONSE, LEARNING, AND BEHAVIORAL-CHANGES
    HENRY, GM
    BUCHSBAUM, M
    MURPHY, DL
    PSYCHOSOMATIC MEDICINE, 1976, 38 (02): : 95 - 105
  • [42] Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease
    Isobe, C.
    Abe, T.
    Kikuchi, T.
    Murata, T.
    Sato, C.
    Hattori, N.
    Terayama, Y.
    MOVEMENT DISORDERS, 2006, 21 : S474 - S475
  • [43] EEG AND REACTION-TIME IN PATIENTS WITH PARKINSONISM BEFORE AND DURING L-DOPA THERAPY
    WIEDERHOLT, WC
    AGENTS AND ACTIONS, 1974, 4 (01): : 61 - 64
  • [44] Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease
    Isobe, C
    Abe, T
    Kikuchi, T
    Murata, T
    Sato, C
    Terayama, Y
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (04) : 346 - 350
  • [45] CARDIOPRESSOR ADAPTABILITY IN PARKINSONIAN-PATIENTS - THE EFFECTS OF COMBINED L-DOPA + NICERGOLINE THERAPY
    MICIELI, G
    MARTIGNONI, E
    CAVALLINI, A
    PACCHETTI, C
    NAPPI, G
    CLINICAL TRIALS JOURNAL, 1987, 24 (05) : 404 - 416
  • [46] Parkinson's Disease and Melanoma: Is There an Increased Incidence of their Joint Occurrence under L-Dopa Therapy?
    Michelmann, S.
    Moll, I.
    Koch, M. O.
    Hauswirth, U.
    AKTUELLE NEUROLOGIE, 2013, 40 (06) : 309 - 314
  • [47] Long term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially with mobility, activities of daily living, and emotional well being
    Santos-Garcia, D.
    Fuster, L.
    Macias, M.
    Llaneza, M. A.
    Echarri, A.
    De la Fuente, R.
    MOVEMENT DISORDERS, 2011, 26 : S296 - S297
  • [48] FAILURE OF MIF-I TO AFFECT BEHAVIORAL-RESPONSES IN PATIENTS WITH PARKINSONS-DISEASE UNDER L-DOPA THERAPY
    CARACENI, T
    PARATI, EA
    GIROTTI, F
    CELANO, I
    FRIGERIO, C
    COCCHI, D
    MULLER, EE
    PSYCHOPHARMACOLOGY, 1979, 63 (03) : 217 - 222
  • [49] L-Dopa/Carbidopa Gel Dose-Response Relationships with Cognitive, Emotional, and Motor Features in Patients with Advanced Parkinson's Disease
    Nissen, T.
    Honig, H.
    Ruessmann, A.
    Fox, K.
    Brown, R.
    Odin, P.
    MOVEMENT DISORDERS, 2010, 25 : S653 - S654
  • [50] Intraintestinal infusion of L-dopa methyl ester in patients with advanced Parkinson's disease: A clinical and pharmacokinetic study
    Stocchi, F
    Vacca, L
    Ruggieri, S
    Olanow, WC
    MOVEMENT DISORDERS, 2002, 17 : S79 - S79
12345